Cargando…

Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer

CDCA3 is an essential regulator in cell mitosis and can regulate many physiological and pathological processes in the human body by stimulating certain proteins such as cell cycle regulatory proteins, transcription factors, and signal transduction molecules. Although several studies have shown that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yingkun, Shen, Meiying, Peng, Yang, Liu, Li, Tang, Lingfeng, Yang, Ting, Pu, Dongyao, Tan, Wenhao, Zhang, Wenjie, Liu, Shengchun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448600/ https://www.ncbi.nlm.nih.gov/pubmed/36082153 http://dx.doi.org/10.1155/2022/4632453

Ejemplares similares

Retracted: Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer
por: International, BioMed Research
Publicado: (2023)

Comprehensive Analysis of Necroptosis-Related Genes as Prognostic Factors and Immunological Biomarkers in Breast Cancer
por: Xu, Yingkun, et al.
Publicado: (2022)

A Pan-Cancer Analysis of the Oncogenic Role of Cell Division Cycle-Associated Protein 4 (CDCA4) in Human Tumors
por: Fang, Hui, et al.
Publicado: (2022)

Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient
por: Phan, Nam Nhut, et al.
Publicado: (2018)

MED16 Promotes Tumour Progression and Tamoxifen Sensitivity by Modulating Autophagy through the mTOR Signalling Pathway in ER-Positive Breast Cancer
por: Li, Han, et al.
Publicado: (2022)

Pyroptosis-Related lncRNAs for Predicting the Prognosis and Identifying Immune Microenvironment Infiltration in Breast Cancer Lung Metastasis
por: Liu, Li, et al.
Publicado: (2022)

CDCA1/2/3/5/7/8 as novel prognostic biomarkers and CDCA4/6 as potential targets for gastric cancer
por: Li, Zhaoxing, et al.
Publicado: (2021)

Cuprotosis-Related Genes: Predicting Prognosis and Immunotherapy Sensitivity in Pancreatic Cancer Patients
por: Xu, Yingkun, et al.
Publicado: (2022)

Cell division cycle associated 2 (CDCA2) upregulation promotes the progression of hepatocellular carcinoma in a p53-dependant manner
por: Wang, Jiahui, et al.
Publicado: (2022)

The Comprehensive Analysis Illustrates the Role of CDCA5 in Breast Cancer: An Effective Diagnosis and Prognosis Biomarker
por: Gao, Yang, et al.
Publicado: (2023)

SDPS-17 COMPREHENSIVE ANALYSIS OF CELL DIVISION CYCLE ASSOCIATED GENE FAMILY EXPRESSION PATTERN AND PROGNOSIS VALUE REVEALS CDCA2 AS A NOVEL ONCOGENE FOR GLIOMA
por: Sun, Wei, et al.
Publicado: (2023)

Pan-cancer analysis identifies CDCA3 as a novel prognostic marker associated with immune infiltration in lung adenocarcinoma through bioinformatics analysis
por: Yang, Hao, et al.
Publicado: (2022)

Development and Validation of a Novel PPAR Signaling Pathway-Related Predictive Model to Predict Prognosis in Breast Cancer
por: Xu, Yingkun, et al.
Publicado: (2022)

A pan-cancer analysis reveals the diagnostic and prognostic role of CDCA2 in low-grade glioma
por: Li, Wenle, et al.
Publicado: (2023)

The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
por: Jin, Xin, et al.
Publicado: (2022)

Prognostic value of CDCA3 in kidney renal papillary cell carcinoma
por: Li, Hao, et al.
Publicado: (2021)

CDCA3 Predicts Poor Prognosis and Affects CD8(+) T Cell Infiltration in Renal Cell Carcinoma
por: Bai, Yuanyuan, et al.
Publicado: (2022)

Pan-Cancer Analysis of the Oncogenic and Immunological Role of RCN3: A Potential Biomarker for Prognosis and Immunotherapy
por: Ding, Jian, et al.
Publicado: (2022)

CDCA3 is a prognostic biomarker for cutaneous melanoma and is connected with immune infiltration
por: Li, Tianhao, et al.
Publicado: (2023)

CDCA8 as an independent predictor for a poor prognosis in liver cancer
por: Shuai, Yu, et al.
Publicado: (2021)

Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
por: Markers, Disease
Publicado: (2023)

CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma
por: Tan, Jianlong, et al.
Publicado: (2022)

Prognostic and Immunological Roles of Cell Cycle Regulator CDCA5 in Human Solid Tumors
por: He, Jing, et al.
Publicado: (2022)

Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy
por: Zhang, Jing, et al.
Publicado: (2022)

Pan-Cancer Analysis Revealed SRSF9 as a New Biomarker for Prognosis and Immunotherapy
por: Liu, Jinhui, et al.
Publicado: (2022)

An Angiogenesis-Related lncRNA Signature Is Associated with Prognosis and Tumor Immune Microenvironment in Breast Cancer
por: Gao, Shun, et al.
Publicado: (2023)

Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis
por: Ci, Chao, et al.
Publicado: (2019)

Overexpression of CDCA8 Predicts Poor Prognosis and Promotes Tumor Cell Growth in Prostate Cancer
por: Wan, Shun, et al.
Publicado: (2022)

CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma
por: Wang, Zhihuai, et al.
Publicado: (2021)

Mechanistic and Clinical Evidence Supports a Key Role for Cell Division Cycle Associated 5 (CDCA5) as an Independent Predictor of Outcome in Invasive Breast Cancer
por: Kariri, Yousif A., et al.
Publicado: (2022)

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
por: Tian, Yunhong, et al.
Publicado: (2018)

High Expression of CDCA7 in the Prognosis of Glioma and Its Relationship with Ferroptosis and Immunity
por: Wang, Yunhan, et al.
Publicado: (2023)

Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma
por: Wang, Jianlin, et al.
Publicado: (2018)

Characterization of starvation response‐related genes for predicting prognosis in breast cancer
por: Wang, Yuan, et al.
Publicado: (2023)

Efficacy evaluation of neoadjuvant chemotherapy in patients with HER2-low expression breast cancer: A real-world retrospective study
por: Tang, Lingfeng, et al.
Publicado: (2022)

CDCA7L promotes glioma proliferation by targeting CCND1 and predicts an unfavorable prognosis
por: Ji, Qian-Kun, et al.
Publicado: (2019)

KIF22 promotes bladder cancer progression by activating the expression of CDCA3
por: Li, Kai, et al.
Publicado: (2021)

The inhibitory effect of silencing CDCA3 on migration and proliferation in bladder urothelial carcinoma
por: Shen, Dexin, et al.
Publicado: (2021)

A mitochondrial function-related LncRNA signature predicts prognosis and immune microenvironment for breast cancer
por: Wang, Yuan, et al.
Publicado: (2023)

YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Hu, Jian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hge77g4q5dfp883gkua2smgsij